查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1456988

全球药品包装市场 - 2024年至2029年预测

Global Pharmaceutical Packaging Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年药品包装市值为955.38亿美元，复合年增长率为16.94%，到2029年市场规模将达到1344.76亿美元。

药品包装市场的成长是由对药物输送装置的需求不断增长、技术进步以及技术进步带来的包装成本降低所推动的。此外，对可重复使用和专业包装的需求不断增长预计也将推动这一时期的市场成长。此外，随着全球电子商务和线上购买趋势的增加，药品也需要坚固的包装以确保产品安全。因此，电子商务行业的成长也正在推动预测期内和未来几年药品包装市场的成长。从地区来看，由于技术采用较早，北美预计将占据最大份额，而美国的医疗保健成本是已开发国家中最高的。亚太地区预计将经历快速成长，特别是由于印度和中国新兴经济体製药业的成长。由于慢性病的流行以及对有效治疗方法药物的需求不断增加，预计亚太地区的药品包装市场也将成长。此外，世界各地个人健康意识的增强预计将为市场在未来几年以永续的速度成长提供机会。

塑胶包装占有很大的市场占有率

塑胶因其多功能性、永续性、耐用性和弹性而成为广泛用于药品包装的材料。各种材料的塑胶瓶用于药品包装，包括聚氯乙烯、聚乙烯、聚丙烯和聚苯乙烯。该行业用于销售和储存的塑料透明、坚固且重量轻。肠外溶液袋、泡壳包装、小袋、预填充式注射器和吸入器以及瓶子均采用塑胶包装。药品包装材料必须易于处理、具有化学惰性，并且对水蒸气的渗透性较低。此外，包装材料与生物製药和药品直接接触，必须遵守监管机构制定的严格规定。

药品包装需求不断成长

包装面临来自其他型态包装的激烈竞争。出于商业目的，製药业也需要玻璃材料包装。製药公司投资药品包装的原因有很多，包括可装载性、破损性和单位成本。为了与其他选择竞争，製造商正在开发耐用、轻量的药品瓶。设计和开发合适的药品包装对于确保药品的安全运输、储存和分配至关重要。最常用于药品包装的材料是塑胶和玻璃。玻璃是首选，因为它易于清洗并且可以让您看到里面的东西。

预计北美在预测期内将出现高速成长。

市场占有率。此外，美国的个人越来越多地从基于数量的护理转向基于价值的护理。我们观察到医疗保健市场动态的变化，从而导致成本更低和患者治疗效果更好。人口老化和慢性疾病患者数量增加等人口变化将进一步推动预测期内药品包装市场的成长。随着疾病的高发病率，患者期待有效的治疗，从而导致技术和服务的进步，使消费者能够更好地控制自己的医疗保健。除了与其他已开发地区不同的医疗保健系统之外，针对有意识和好奇的人群开拓有效的医疗保健策略将导致该地区药品包装市场在预测期内的增长带来更好的医疗保健需求。

主要市场推出

  • 2023 年 11 月，以创造和製造环保包装解决方案而闻名的国际公司 Amcor Plc 与永续聚乙烯领先製造商 NOVA Chemicals Corporate 签署了谅解备忘录。根据协议，NOVA Chemicals Corporate 将供应用于软包装薄膜的机械回收聚乙烯树脂 (rPE)。
  • 2023 年 7 月，Constantia Flexibles 推出了 REGULA CIRC，这是一种新型冷成型箔基药品包装解决方案。这种包装采用PE密封层取代传统的PVC，减少了塑胶的用量，增加了铝的用量。这种优化不仅提高了包装的永续性，而且有利于回收过程中的材料回收。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球药品包装市场：依原料分类

  • 介绍
  • 塑胶和聚合物
  • 玻璃
  • 纸和纸板
  • 金属箔
  • 其他的

第六章全球药品包装市场：依药品剂量类型

  • 介绍
  • 液体剂量
  • 固态剂型
  • 半固体和加压产品

第七章全球药品包装市场：依包装类型

  • 介绍
  • 泡壳包装
  • 预填充注射器
  • 医疗专用袋
  • 管瓶和安瓿
  • 袋和条袋
  • 其他的

第八章全球药品包装市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Amcor plc
  • CCL Industries
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • ONCAP（Precision Concepts International）
  • SVP Global（Klockner Pentaplast）
  • Carl Zeiss Foundation（SCHOTT AG）
  • Enhanced Equity Fund（Aphena Pharma Solutions）
  • Sonoco Products Company
  • Ampersand Capital Partners（Tjoapack LLC）
简介目录
Product Code: KSI061610047

The global pharmaceutical packaging market is evaluated at US$95.538 billion for the year 2022 growing at a CAGR of 16.94% reaching the market size of US$134.476 billion by the year 2029.

The growth of the pharmaceutical packaging market is driven by the increasing demand for drug delivery devices, technological advancements, and a reduction in the packaging cost with the advancement in technology. A rise in the demand for reusable and speciality packaging is also expected to bolster the market growth during the given time frame. Additionally, with the growing e-commerce and online purchasing trend worldwide, drugs also need robust packaging keeping in view the safety of the product. Hence, the growing e-commerce industry is also driving the growth of the global pharmaceutical packaging market in the forecast period and in the upcoming years. On the basis of geography, North America is expected to hold a major share owing to the early adoption of technology, and the highest health expenditure of the United States among all the developed regions of the world. While the Asia Pacific region is expected to be the fastest-growing, this is due to the growing pharmaceutical industry, especially in the emerging economies of India and China. Also, with the prevalence of chronic diseases in the APAC region, the market for pharmaceutical packaging is projected to thrive due to the increasing demand for drugs supported by effective treatment procedures. Furthermore, growing health awareness among individuals worldwide is expected to provide an opportunity for the market to grow at a sustainable pace in the upcoming years.

Plastic packaging holds a significant market share

Plastic is a widely used material for pharmaceutical packaging due to its versatility, sustainability, durability, and flexibility. Plastic bottles made of different materials, such as polyvinyl chloride, polyethylene, polypropylene, and polystyrene, are used in pharmaceutical packaging. The plastic used in this industry for marketing and storage is clear, strong, and lightweight. Parenteral solution pouches, blister packs, sachets, prefilled syringes and inhalers, and bottles are all packaged with plastics. Pharmaceutical packaging materials must be easily handled, chemically inert, and have a low permeability to water vapour. Furthermore, packaging materials must adhere to stringent regulations set forth by regulatory bodies because they come into direct contact with biological agents and pharmaceuticals.

Growing need for pharmaceutical packaging

The packaging faces stiff competition from other forms of packaging. For commercial purposes, the pharmaceutical industry is also looking for glass material packaging. Pharma companies invest in pharmaceutical packaging for a variety of reasons, including loadability, breakages, and unit cost. To compete with alternative options, manufacturers are creating sturdy, lightweight bottles for pharmaceuticals. It is imperative to design and develop suitable packaging for pharmaceutical items in order to guarantee the safe transportation, storage, and dispensing of medications-some of which have the potential to save lives. The two materials most frequently used in pharmaceutical packaging are plastic and glass. Glass is usually preferred because of its features that make it easy to clean and allow you to see what's inside.

North America is expected to grow at a high rate during the forecast period.

The global pharmaceutical packaging market is estimated to hold the largest market share owing to the highest health spending in the United States, healthcare services are very expensive, most of the people in the country have medical insurance, and the country does not have a universal healthcare system. Additionally, there is a rising trend in the United States where individuals are moving from volume-based to value-based care. A shift in the healthcare market dynamics is being observed which is further leading to better patient outcomes at lower costs. Changing demographics like an aging population, and a high prevalence of people with chronic diseases are further driving the growth of the pharmaceutical packaging market in the forecast period. With the high prevalence of diseases, patients look forward to effective treatments and this has led to advancements in technology and services providing consumers be in greater control of their own health management. Designing effective healthcare strategies according to the highly aware and curious citizens in addition to the unique healthcare system among the other developed regions has created a need for the provision of better health services emanating from the growth of the global pharmaceutical packaging market in this region during the forecast period.

Market key launches

  • In November 2023, a Memorandum of Understanding (MOU) has been disclosed between Amcor Plc, a well-known international business recognized for its creation and manufacturing of environmentally friendly packaging solutions, and NOVA Chemicals Corporate, a top manufacturer of sustainable polyethene. Under the terms of the agreement, NOVA Chemicals Corporate will supply mechanically recycled polyethylene resin (rPE), which will be used to make flexible packaging films. By utilizing more rPE in flexible packaging applications, this initiative is in line with Amcor's commitment to promoting packaging circularity.
  • In July 2023, Constantia Flexibles unveiled REGULA CIRC, a novel coldform foil-based pharmaceutical packaging solution. The packaging substitutes a PE sealing layer for traditional PVC, which lowers the amount of plastic and increases the amount of aluminium. This optimization boosts material recovery during recycling procedures in addition to improving the packaging's sustainability.

Segmentation:

By Raw Material

  • Plastics and Polymers
  • Glass
  • Paper and Paperboard
  • Metal Foils
  • Others

By Pharmaceutical Dosage Type

  • Liquid Dosage
  • Solid Dosage
  • Semi Solid and Pressurized Products

By Packaging Type

  • Blister Packs
  • Pre-Fillable Syringes
  • Medical Specialty Bags
  • Vials and Ampoules
  • Pouches and Strip Bags
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 5.1. Introduction
  • 5.2. Plastic and Polymers
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Glass
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Paper and Paperboard
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Metal Foils
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Trends and Opportunities
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PHARMACEUTICAL DOSAGE TYPE

  • 6.1. Introduction
  • 6.2. Liquid Dosage
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Solid Dosage
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Semi Solid and Pressurized Products
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE

  • 7.1. Introduction
  • 7.2. Blister Packs
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Pre-Fillable Syringes
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Medical Specialty Bags
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Vials and Ampoules
    • 7.5.1. Market Trends and Opportunities
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness
  • 7.6. Pouches and Strip Bags
    • 7.6.1. Market Trends and Opportunities
    • 7.6.2. Growth Prospects
    • 7.6.3. Geographic Lucrativeness
  • 7.7. Others
    • 7.7.1. Market Trends and Opportunities
    • 7.7.2. Growth Prospects
    • 7.7.3. Geographic Lucrativeness

8. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Raw Material
    • 8.2.2. By Pharmaceutical Dosage Type
    • 8.2.3. By Packaging Type
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Raw Material
    • 8.3.2. By Pharmaceutical Dosage Type
    • 8.3.3. By Packaging Type
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Raw Material
    • 8.4.2. By Pharmaceutical Dosage Type
    • 8.4.3. By Packaging Type
    • 8.4.4. By Country
      • 8.4.4.1. UK
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Raw Material
    • 8.5.2. By Pharmaceutical Dosage Type
    • 8.5.3. By Packaging Type
    • 8.5.4. By Country
      • 8.5.4.1. UAE
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. Saudi Arabia
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Raw Material
    • 8.6.2. By Pharmaceutical Dosage Type
    • 8.6.3. By Packaging Type
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Others
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Amcor plc
  • 10.2. CCL Industries
  • 10.3. Gerresheimer AG
  • 10.4. West Pharmaceutical Services, Inc.
  • 10.5. ONCAP (Precision Concepts International)
  • 10.6. SVP Global (Klockner Pentaplast)
  • 10.7. Carl Zeiss Foundation (SCHOTT AG)
  • 10.8. Enhanced Equity Fund (Aphena Pharma Solutions)
  • 10.9. Sonoco Products Company
  • 10.10. Ampersand Capital Partners (Tjoapack LLC)